📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: BioBDx

1.1 - Company Overview

BioBDx Logo

BioBDx

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of technologies for the diagnosis and management of neurological and psychiatric conditions, including the Quotient ADHD System, a tool that aids in the objective and accurate assessment of ADHD symptoms. Dedicated to delivering high-value information to physicians, parents and patients to guide personalized strategies and enhance quality of life for patients with ADHD.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to BioBDx

Contineum Therapeutics Logo

Contineum Therapeutics

HQ: United States Website
  • Description: Provider of novel oral small molecule therapies for neuroscience, inflammation, and immunology, including PIPE-791, an LPA1R antagonist in development for idiopathic pulmonary fibrosis (IPF) and progressive multiple sclerosis (PMS); PIPE-307, a selective M1 receptor inhibitor in development for relapsing-remitting multiple sclerosis (RRMS) and depression; and LPA1R DC, a peripherally restricted LPA1R antagonist.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Contineum Therapeutics company profile →
Onward Logo

Onward

HQ: The Netherlands Website
  • Description: Provider of an implantable neuro-stimulation system (INS) with real-time motion feedback and training tools to rehabilitate patients with neurological disorders, including spinal cord injury (SCI).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Onward company profile →
Trophos Logo

Trophos

HQ: France Website
  • Description: Provider of clinical-stage pharmaceutical R&D developing innovative therapeutics for under-served needs in neurology and cardiology, with a pipeline of original molecules targeting motoneuron diseases such as amyotrophic lateral sclerosis (ALS).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Trophos company profile →
Protagenic Therapeutics Logo

Protagenic Therapeutics

HQ: United States Website
  • Description: Provider of biotechnology solutions developing naturally occurring human brain hormones to treat anxiety- and depression-based mood disorders. Offers PT00114, a synthetic analog of the neuropeptide TCAP that regulates stress response for depression, PTSD, anxiety, and addiction, and the TCAP R&D platform to address neuropsychiatric and neurodegenerative diseases at the cellular level in the brain.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Protagenic Therapeutics company profile →
Wallaby Medical Logo

Wallaby Medical

HQ: United States Website
  • Description: Provider of the Avenir coil system and medical devices for stroke treatment, operating as a manufacturing company.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Wallaby Medical company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for BioBDx

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to BioBDx

2.2 - Growth funds investing in similar companies to BioBDx

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for BioBDx

4.2 - Public trading comparable groups for BioBDx

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to BioBDx

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About BioBDx

What does BioBDx do?

BioBDx is a provider of technologies for the diagnosis and management of neurological and psychiatric conditions, including the Quotient ADHD System, a tool that aids in the objective and accurate assessment of ADHD symptoms. Dedicated to delivering high-value information to physicians, parents and patients to guide personalized strategies and enhance quality of life for patients with ADHD.

Who are BioBDx's competitors?

BioBDx's competitors and similar companies include Contineum Therapeutics, Onward, Trophos, Protagenic Therapeutics, and Wallaby Medical.

Where is BioBDx headquartered?

BioBDx is headquartered in United States.

How many employees does BioBDx have?

BioBDx has 1,000 employees 🔒.

When was BioBDx founded?

BioBDx was founded in 2010 🔒.

What sector and industry vertical is BioBDx in?

BioBDx is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for BioBDx

Who are the top strategic acquirers in BioBDx's sector and industry

Top strategic M&A buyers and acquirers in BioBDx's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for BioBDx?

Top strategic M&A buyers groups and sectors for BioBDx include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in BioBDx's sector and industry vertical

Which are the top PE firms investing in BioBDx's sector and industry vertical?

Top PE firms investing in BioBDx's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in BioBDx's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in BioBDx's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in BioBDx's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to BioBDx include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in BioBDx's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for BioBDx?

The key public trading comparables and valuation benchmarks for BioBDx include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for BioBDx for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for BioBDx with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in BioBDx's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for BioBDx with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in BioBDx's' sector and industry vertical?

Access recent funding rounds and capital raises in BioBDx's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for BioBDx